BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-494@pharmaconomics
DTSTAMP:20260707T014707Z
DTSTART;VALUE=DATE:20260320
DTEND;VALUE=DATE:20260321
SUMMARY:BMY Approval — Opdivo
DESCRIPTION:A final FDA approval decision on Opdivo for Hodgkin Lymphoma is expected Mar 20\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000008/a2026q1ex991.htm\n\nTrack it: https://pharmaconomics.com/e/494
URL:https://pharmaconomics.com/e/494
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:BMY catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR